The Executive Board is the chief management body of Charité. It is responsible for ensuring that Charité performs its mission and realizes its goals in the areas of research, teaching, patient care, and translation. It is also responsible for fulfilling the institution’s agreements with the State of Berlin.
You are here:
Prof. Dr. Heyo K. Kroemer
Chief Executive Officer
In his role as CEO, Prof. Kroemer represents Charité in all matters. He is responsible for structural and economic corporate development, making certain that Charité’s various goals are all integrated and that clinical and scientific needs and interests are balanced. Prof. Kroemer has been the CEO of Charité since September 2019.
Heyo K. Kroemer was born in Leer, in Germany’s East Frisia region, on April 4, 1960. He studied pharmacy at the Technical University of Braunschweig, where he received his doctorate (Dr. rer. nat.). Following periods of study and research in Basel, Switzerland, and Nashville, Tennessee, he completed the habilitation process in Tübingen, writing his habilitation thesis in the subjects of pharmacology and toxicology. Kroemer was appointed to a position at the University of Greifswald in 1998, where he worked on molecular and clinical issues in drug metabolism in the field of general pharmacology. He served as the dean of the Faculty of Medicine at the University of Greifswald from 2000 until 2012, and starting in 2011, he was also the Chief Scientific Officer of Universitätsmedizin Greifswald. He served full-time as Dean and Executive Board Spokesperson of University Medical Center Göttingen (UMG) from 2012 until 2019 and as the President of the Council of the Faculty of Medicine. Prof. Kroemer is also a member of the German National Academy of Sciences, Leopoldina; the Executive Board of the Association of German University Medical Centers (Verband der Universitätsklinika Deutschlands); the Berlin-Brandenburg Academy of Sciences and Humanities; and the German National Academy of Science and Engineering, acatech.
Prof. Dr. Joachim Spranger
In the role of Dean, Prof. Spranger is responsible for all matters of research and teaching at Charité. He is the member of the Executive Board of Charité in charge of scientific affairs and chairs both the Faculty Board and Faculty Council. Prof. Spranger has been the Dean of Charité since January 2023.
Joachim Spranger was born in Cologne in 1970. He completed both his studies in human medicine and his doctorate at Ruhr-Universität Bochum. In 2005, he qualified as a professor in the field of internal medicine at Charité. Spranger was appointed to serve as Heisenberg Professor of Diabetology at Charité in 2008. He then became the Director of the Department of Endocrinology and Metabolic Diseases at Charité, a role he took on in 2011, and the head of the Department of Endocrinology and Metabolic Diseases at Labor Berlin – Charité Vivantes GmbH. He sat on the Faculty Board as Vice Dean of Education from January 2017 to April 2022 and was also a member of the Faculty Council for many years, serving as its spokesperson from 2015 to 2017. Spranger, who specializes in endocrinology, also served as the spokesperson of the Clinical Research Unit at the Berlin Institute of Health at Charité (BIH) from 2014 until 2018.
Prof. Dr. Martin E. Kreis
Chief Medical Officer
In the role of Chief Medical Officer, Prof. Kreis is responsible for the development of patient care and for integrating it into the overall development of Charité. He is also the head of the Hospital Management. Prof. Kreis has served in the role of Chief Medical Officer since January 2021.
Martin E. Kreis was born in Ludwigsburg in 1967. He earned his degree in medicine at the University of Tübingen, where he studied from 1986 until 1993. He has been a specialist in surgery since 2001 and completed the habilitation process in 2003. He served as a senior physician and head of the Division of Colorectal Surgery of the Department of Surgery of the Grosshadern Campus of LMU Munich from 2004 until 2012. Kreis took over as head of the intestinal center there in 2009 and became chief physician in 2010. He is an expert on surgical treatment of gastrointestinal disease and on treating chronic inflammatory bowel disease and colorectal cancer. He served as Director of the Department of General, Visceral and Vascular Surgery at Charité’s Campus Benjamin Franklin from 2012 until 2020 and Medical Director of the Charité Center for Surgery from 2018 until 2020.
Prof. Dr. Christopher Baum
Chief Translational Research Officer and Chair of the BIH Board of Directors
In the role of Chair of the BIH Board of Directors, Prof. Baum also serves as Chief Translational Research Officer of Charité, a position that was created in 2021 during the integration of BIH to form the Berlin Institute of Health at Charité (BIH). Prof. Baum represents the field of translational research in dealings with internal and external audiences. He has held the role of Chief Translational Research Officer since January 2021.
Christopher Baum was born in Marburg on April 13, 1962. He studied medicine in Essen, Freiburg and Hamburg. He obtained his doctorate in 1991 and completed the habilitation process in the field of molecular medicine at the University of Hamburg in 1999. He joined the Hannover Medical School (MHH) as a professor of stem cell biology in 2000 and led the Institute of Experimental Hematology there starting in 2006. Baum became the Dean of Research and then President of MHH in 2013. He moved to the University of Lübeck in 2019 in the role of Vice President for Medicine and a member of the Board of Directors of University Hospital Schleswig-Holstein (UKSH). Baum took an early interest in gene therapy in his scientific research and then began focusing on translational research networks as a scientific manager. He has been a member of the board of Medizinischer Fakultätentag, a body representing medical schools in Germany, since 2019. Baum has been with the BIH since October 2010, initially in the role of Chairman of the Board of Directors and then, since January 2021, as Chief Translational Research Officer of Charité as well.
Chief Financial and Infrastructure Officer
In the role of Chief Financial and Infrastructure Officer, Astrid Lurati is responsible for managing all of Charité’s financial and economic affairs. These include investment planning and consolidation of annual financial statements, along with equipment, construction, and property matters and the entire field of sustainability. Lurati has been a member of the Executive Board of Charité since May 2016, first as Hospital Director and, since late 2019, as Chief Financial and Infrastructure Officer.
Astrid Lurati was born in Minden, Westphalia, on February 9, 1966. After a vocational training program in business and commerce, she completed her studies of business administration in 1994 with the degree of Diplom from the University of Hamburg. She also earned a Master of Pharmaceutical Medicine from Witten/Herdecke University, where she studied from 1997 until 1999. Lurati was in charge of the Department of Strategic Pharmaceutical Planning at Bayer AG in Leverkusen starting in 1997, later moving to Investor Relations. She took on the role of Business Director at the University Medical Center Hamburg-Eppendorf (UKE) in 2003 and assumed responsibility for finances there in 2004. She became Deputy Commercial Director of UKE in 2007 and also served intermittently as Acting Commercial Director during this time.
Chief Human Resources Officer / Chief Nursing Officer
In the role of Chief Human Resources Officer / Chief Nursing Officer, Carla Eysel is responsible for all human resources matters, including collective agreement negotiations and the powers of the service authority, higher service authority, personnel office, and personnel budget office. This position was newly created to represent the Charité brand as an employer and recruit and retain skilled workers more effectively. Eysel has held the role of Chief Human Resources Officer / Chief Nursing Officer since November 2020.
Carla Eysel was born in Reutlingen on January 24, 1972. She studied law in Regensburg and Tübingen and took her exams to become a trainee lawyer in Düsseldorf. Eysel was admitted to the bar in 1999 and holds a master’s degree in international management from the University of East London. As a specialized attorney for labor and employment law, she began working at TÜV Rheinland Holding AG, where she took on the role of Head of HR for Industrial Service in 2001. She also served as a member of the executive management and a representative with the employer association Tarifgemeinschaft TÜV. She moved to ALBA Holding in the role of Head of Business Development and Organization in 2007. As her duties broadened and she managed various large-scale projects, she was named general representative of the ALBA Group in 2017 and finally became CEO of ALBA Europe in 2019.